GlassScriptPhysician profile
Clayton Bert Alexander
NPI 1992794879
$4,616.12
in general payments reported to CMS, 2019-2025
34 companies · $50.23 in 2025
The $50.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $448 · 2021: $1,104 · 2022: $2,058 · 2023: $361 · 2024: $101 · 2025: $50.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.18 |
| Education | $124.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2022 | |
| Astellas Pharma US INC | $390.96 | 2019-2024 | |
| Abbvie INC. | $347.65 | 2021-2023 | Qulipta |
| Novartis Pharmaceuticals Corporation | $334.02 | 2019-2023 | |
| Glaxosmithkline, LLC. | $313.87 | 2019-2023 | Shingrix |
| Pfizer INC. | $224.79 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $217.83 | 2019-2023 | Verquvo, Belsomra |
| Lilly USA, LLC | $166.12 | 2019-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $147.18 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $118.19 | 2021 | |
| Jazz Pharmaceuticals INC. | $116.15 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $105.86 | 2020-2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.39 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $89.73 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.45 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $69.13 | 2021-2023 | Rexulti |
| Mylan Specialty L.P. | $64.85 | 2021-2024 | Yupelri |
| Kowa Pharmaceuticals America, INC. | $63.89 | 2020-2023 | Livalo, Seglentis |
| Abbott Laboratories | $62.04 | 2021-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $45.98 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.46 | 2022-2023 | Caplyta |
| Xeris Pharmaceuticals, INC. | $40.82 | 2022 | |
| Amarin Pharma, INC. | $35.40 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.42 | 2021 | |
| Biodelivery Sciences International, INC. | $30.56 | 2019 | |
| Dermira, INC. | $27.36 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.55 | 2020-2021 | |
| Allergan, INC. | $24.28 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $20.06 | 2022 | |
| Lundbeck LLC | $16.13 | 2021 | |
| Insulet Corporation | $16.01 | 2021 | |
| Dexcom, INC. | $15.98 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.28 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.